MedTrace Logo

Serum TWEAK Levels in Acne Vulgaris

NCT05684861 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2023-01-13

No results posted yet for this study

Summary

Evaluate the serum level of TWEAK in patients with AV and their relations before and after treatment with isotretinoin.

Conditions

  • Acne Vulgaris

Interventions

DRUG

Isotretinoin

systemic isotretinoin was given to all 90 patients , dose was prescribed according to weight for 3 months

DIAGNOSTIC_TEST

ELISA Assays of Serum TWEAK.

: From each subject, 5mL of blood was collected into vacutainers before and after treatment with isotretinoin. The blood samples were centrifuged at 3000g for 10 min at a temperature of 4°C, then . Quantitative determinations for serum TWEAK were achieved using the corresponding commercially available ELISA kit supplied by the AssayMax

Sponsors & Collaborators

  • South Valley University

    lead OTHER

Principal Investigators

  • Hassan M Ibrahim, professor · South Valley University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-20
Completion
2023-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05684861 on ClinicalTrials.gov